Understanding what matters to metastatic castration‐resistant prostate cancer (mCRPC) patients when considering treatment options: A US patient preference survey
暂无分享,去创建一个
D. George | M. Botteman | M. Karimi | A. Mohamed | Jui-Hua Tsai | Sayeli Jayade | N. Ning | S. Jayade